Open Access

A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells

  • Authors:
    • Seong-Yeong Heo
    • Seok-Chun Ko
    • Chang Su Kim
    • Gun-Woo Oh
    • Bomi Ryu
    • Zhong‑Ji Qian
    • Geunhyung Kim
    • Won Sun Park
    • Il-Whan Choi
    • Thi Tuong Vy Phan
    • Soo-Jin Heo
    • Do-Hyung Kang
    • Myunggi Yi
    • Won-Kyo Jung
  • View Affiliations

  • Published online on: April 4, 2017     https://doi.org/10.3892/ijmm.2017.2941
  • Pages: 1072-1082
  • Copyright: © Heo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In this study, a marine microalga Spirulina sp.-derived protein was hydrolyzed using gastrointestinal enzymes to produce an angiotensin I (Ang I)-converting enzyme (ACE) inhibitory peptide. Following consecutive purification, the potent ACE inhibitory peptide was composed of 7 amino acids, Thr-Met‑Glu‑Pro‑Gly‑Lys-Pro (molecular weight, 759 Da). Analysis using the Lineweaver-Burk plot and molecular modeling suggested that the purified peptide acted as a mixed non-competitive inhibitor of ACE. The inhibitory effects of the peptide against the cellular production of vascular dysfunction-related factors induced by Ang II were also investigated. In human endothelial cells, the Ang II-induced production of nitric oxide and reactive oxygen species was inhibited, and the expression of inducible nitric oxide synthase (iNOS) and endothelin-1 (ET-1) was downregulated when the cells were cultured with the purified peptide. Moreover, the peptide blocked the activation of p38 mitogen‑activated protein kinase. These results indicated that this Spirulina sp.-derived peptide warrants further investigation as a potential pharmacological inhibitor of ACE and vascular dysfunction.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 39 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Heo S, Ko S, Kim CS, Oh G, Ryu B, Qian ZJ, Kim G, Park WS, Choi I, Phan TT, Phan TT, et al: A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells. Int J Mol Med 39: 1072-1082, 2017
APA
Heo, S., Ko, S., Kim, C.S., Oh, G., Ryu, B., Qian, Z. ... Jung, W. (2017). A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells. International Journal of Molecular Medicine, 39, 1072-1082. https://doi.org/10.3892/ijmm.2017.2941
MLA
Heo, S., Ko, S., Kim, C. S., Oh, G., Ryu, B., Qian, Z., Kim, G., Park, W. S., Choi, I., Phan, T. T., Heo, S., Kang, D., Yi, M., Jung, W."A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells". International Journal of Molecular Medicine 39.5 (2017): 1072-1082.
Chicago
Heo, S., Ko, S., Kim, C. S., Oh, G., Ryu, B., Qian, Z., Kim, G., Park, W. S., Choi, I., Phan, T. T., Heo, S., Kang, D., Yi, M., Jung, W."A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells". International Journal of Molecular Medicine 39, no. 5 (2017): 1072-1082. https://doi.org/10.3892/ijmm.2017.2941